Search

everythinglearnresearchcommunity

for

Search:↓

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Aging in men is influenced by genetics and lifestyle, leading to muscle loss, bone issues, and skin damage.

Women with acne have lower levels of a specific hormone marker than women without acne.

Berberine may reduce prostate enlargement by blocking inflammation.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Testosterone undecanoate safely and effectively increased penis size in male children with 5-alpha-reductase deficiency.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.